Related Experiment Videos
Inflammation and infection in clinical stroke
Hedley C A Emsley1, Pippa J Tyrrell
1University of Manchester and Stroke Services, Clinical Sciences Building, Hope Hospital, Eccles Old Road, Salford, M6 8HD, U.K. hemsley@fs1.ho.man.ac.uk
Summary
Inflammation plays a critical role in stroke, both before its onset as a risk factor and after, influencing injury and repair. Targeting inflammatory pathways offers promising therapeutic strategies for stroke treatment.
Area of Science:
- Neuroscience
- Immunology
- Cardiovascular Medicine
Background:
- Stroke, a leading cause of disability, involves complex inflammatory processes.
- Atherosclerosis, a primary cause of ischemic stroke, is fundamentally an inflammatory condition.
- Inflammation in both the periphery and central nervous system (CNS) contributes to stroke development and outcomes.
Purpose of the Study:
- To explore the multifaceted role of inflammation in stroke pathophysiology.
- To identify inflammatory mechanisms as potential therapeutic targets for stroke.
- To review current and emerging treatment strategies targeting inflammation in stroke.
Main Methods:
- Review of existing literature on inflammation and stroke.
- Analysis of molecular and cellular mediators of inflammation in stroke.
- Evaluation of clinical data linking inflammatory conditions to stroke risk and outcomes.
Main Results:
- Inflammation is implicated in stroke predisposition, acute injury, and long-term repair.
- Cytokines, leukocytes, and microglia are key cellular and molecular players in stroke-related inflammation.
- Inflammatory conditions and infections are identified as significant stroke risk factors.
Conclusions:
- Inflammation is a pivotal factor in stroke, offering opportunities for novel therapeutic interventions.
- Existing stroke treatments like aspirin and statins may exert effects through anti-inflammatory mechanisms.
- Targeting inflammatory pathways, such as with cytokine antagonism, represents a promising therapeutic avenue for stroke.